Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 10 of 35
Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas
NCT04505293
Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
NCT05028361
Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
NCT05052580
Simultaneous RZV and aIIV4 Vaccination
NCT05007041
Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)
NCT04570722
An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE)
NCT04763174
Amplifying Sensation in Underactive Bladder
NCT04516434
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267
PEEP Mask for Tracheobronchomalacia-Induced Cough
NCT04169282
Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status Asthmaticus
NCT04874610
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)
NCT05966155
Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019
NCT04883528
A Transition of Care Model From Hospital to Community for Hispanic/Latino Adult Patients With Diabetes.
NCT04864639
VAC Bioburden Wound Care Assessment
NCT04826965
Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19)
NCT04914364
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
NCT04075370
Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular Risk
NCT04356183
Development and Validation of a Model to Predict Fast Progression in Glaucoma
NCT04454190
COA-APTIC Caregiver Concept Elicitation Study
NCT04392180
EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan
NCT04933812
TOPS for African American Breast Cancer Survivors
NCT04741802
Human Use Condition Study- Evaluation of Implanted Leads in Humans
NCT04320849
Implementation of Cognitive Stimulation Therapy
NCT04754932
Observational Maternal COVID-19 Vaccination Study
NCT04826640
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
NCT02590393
Ultrasound After Total Shoulder Arthroplasty
NCT04416932
A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers
NCT04816708
Resilience Measurement in Older Adults With Late-Stage Lung Cancer
NCT04825912
Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma
NCT04247971
Efficacy and Safety of ICD Remote Monitored Exercise Testing to Improve Heart Failure Outcomes: REMOTE HF-ACTION
NCT04629066
COVID-19 Surveillance and Exposure Testing in School Communities
NCT04831866
Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss
NCT04739436
Enhancing Physical Function in the Long-term for Older Adults
NCT04490356
Latinx Teen Depression Treatment Study
NCT04819295
Active Dads Healthy Families
NCT04505085
Opioid & Steroid Use Following Tonsillectomy in Pediatric Patients
NCT04541147
Childhood Obesity Microbiome Study
NCT04770311
AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19
NCT04649775
Outcomes of a Self-guided Versus Therapist-guided Online Mental Health Treatment
NCT04810988
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
NCT04949243
Mindfulness and CBT for Sleep
NCT04736056
Learning Health for Pediatric Complex Care Integration (PCCI)
NCT05056480
Impact of Reduced Cannabis Use on Functional Outcomes (R33 Phase)
NCT04567238
Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
NCT04792970
An Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder
NCT04498754
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
NCT04710212
Presyncope (Syncope) Prevention Study
NCT04772755
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)
NCT05966129
Evaluation of Full Face Snorkel Masks (FFSMs)
NCT04783688
Digital Intervention To Improve Diet Quality
NCT04098016
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.